Skip to content

Author

Hannah Pearl

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Patterns of treatment-related adverse events and treatment discontinuation in phase III oncology clinical trials.

466 Background: Treatment-related adverse events (TRAEs) are a common cause of discontinuation in cancer clinical trials. Although TRAEs are routinely documented, the relative contributions of patients (pts), clinicians, and protocol-mandated requirements to these decisions remain poorly characterized. We sough...

Hannah Pearl, Breanna Yi-Zhu Yang, Jacob Abrahams et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.